MGNet: New Assay Evaluates Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Myasthenia Gravis
Aug 15, 2022 ·
1m 42s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Neuroimmunology & Neuroinflammation on April 26, 2022, titled "Heterogeneity...
show more
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Neuroimmunology & Neuroinflammation on April 26, 2022, titled "Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis."
Read the paper here: https://nn.neurology.org/content/9/4/e1169
Learn more about MGNet: https://www.rarediseasesnetwork.org/mgnet
show less
Read the paper here: https://nn.neurology.org/content/9/4/e1169
Learn more about MGNet: https://www.rarediseasesnetwork.org/mgnet
Information
Author | RDCRN |
Organization | RDCRN |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company